GI & Endoscopy

Here are eight updates on GI companies from the past week.

Allegan, Forest Laboratories and Ironwood Pharmaceuticals accused Sandoz of patent infringement in a lawsuit to prevent Sandoz from bringing a generic version of Linzess to market, Delaware Law Weekly reports.

Gastroenterologist salary and compensation varies by region of the country, experience and practice setting. Here are 14 things to know.

The FDA approved the radioactive drug Lutathera for the treatment of gastroenteropancreatic neuroendocrine tumors. This is the first time a radiopharmaceutical has been approved for the treatment of GEP-NETs.

Michael Brophy, MD, is a gastroenterologist at Spokane, Wash.-based Rockwood Digestive Health Center.

New York City-based Mount Sinai Health System opened Mount Sinai Doctors Palm Beach (Fla.) focused on bringing primary care, cardiology, gastroenterology and ophthalmology services to the area.

Olympus added a new product to its EndoTherapy portfolio when it became the exclusive distributor of Intelligent Endoscopy's SmartBand Multi-Band Ligation Kit.

Innovate Biopharmaceuticals completed its reverse merger with Monster Digital, entirely absorbing the company and becoming a publicly traded entity.

Evangelical Community Hospital will acquire Central Penn Gastroenterology Associates, effective July 2, The Daily Item reports. Both organizations are based in Lewisburg, Pa.

Kenneth Mirkin, MD, is a gastroenterologist at Fairfax-based Gastroenterology Associates of Northern Virginia.